These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35041375)

  • 1. Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram.
    Xue W; Fu T; Deng S; Yang F; Yang J; Zhu F
    ACS Chem Neurosci; 2022 Feb; 13(3):340-351. PubMed ID: 35041375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
    Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
    Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
    Murray KE; Ressler KJ; Owens MJ
    Pharmacol Biochem Behav; 2016 Feb; 141():50-7. PubMed ID: 26621784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations.
    Islas ÁA; Scior T
    Molecules; 2022 May; 27(9):. PubMed ID: 35566327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
    Plenge P; Gether U; Rasmussen SG
    Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of serotonin transporter expression by escitalopram under inflammation.
    Mena S; Cruikshank A; Best J; Nijhout HF; Reed MC; Hashemi P
    Commun Biol; 2024 Jun; 7(1):710. PubMed ID: 38851804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.
    Sánchez C
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):91-5. PubMed ID: 16918708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.
    Plenge P; Abramyan AM; Sørensen G; Mørk A; Weikop P; Gether U; Bang-Andersen B; Shi L; Loland CJ
    Nat Commun; 2020 Mar; 11(1):1491. PubMed ID: 32198394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.
    Zhang L; Rasenick MM
    J Pharmacol Exp Ther; 2010 Mar; 332(3):977-84. PubMed ID: 19996298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.
    Matthäus F; Haddjeri N; Sánchez C; Martí Y; Bahri S; Rovera R; Schloss P; Lau T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1806-1817. PubMed ID: 27665061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.
    Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K
    ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations.
    Zhang Y; Zheng G; Fu T; Hong J; Li F; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2020 Mar; 22(9):5132-5144. PubMed ID: 32073004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors.
    Salomon K; Abramyan AM; Plenge P; Wang L; Bundgaard C; Bang-Andersen B; Loland CJ; Shi L
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2304089120. PubMed ID: 37792512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
    Jacquot C; David DJ; Gardier AM; Sánchez C
    Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.
    Mnie-Filali O; Lau T; Matthaeus F; Abrial E; Delcourte S; El Mansari M; Pershon A; Schloss P; Sánchez C; Haddjeri N
    CNS Neurosci Ther; 2016 Aug; 22(8):691-9. PubMed ID: 27171685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.